Although our study has a limitation regarding lack of functional studies and the frequency of this novel PLA2G6 mutation await future examinations, we believe that the recognition of genetic defects related to INAD will eventually shed light on the underlying pathological mechanisms and help improve more effective management plans for INAD subjects in the future. This evidence concerns the gene PLA2G6 and neurodegeneration with brain iron accumulation 2A.